{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-199683","form_type":"8-K","ticker":"INO","cik":"0001055726","company_name":"INOVIO PHARMACEUTICALS, INC.","filed_at":"2023-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.033840+00:00","generated_at":"2026-06-12T16:46:03.155825+00:00","sec_items":["2.05"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Inovio cuts 30% of workforce (58 employees) in reorganization plan; expects $2.1M charge, $9.9M annual savings","bullets":["Reduction in force of 58 employees (~30% of full-time employees) committed on July 31, 2023.","One-time pre-tax charge of ~$2.1M in Q3 2023 mainly for severance and benefits.","Expects annual cost savings of ~$9.9M from the restructuring.","Cash payments for severance expected by October 31, 2023; charges incurred by Sept 30, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-199683","json":"https://secwatch.observer/filing/0001193125-23-199683.json","markdown":"https://secwatch.observer/filing/0001193125-23-199683.md","text":"https://secwatch.observer/filing/0001193125-23-199683.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1055726/000119312523199683/0001193125-23-199683-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1055726/000119312523199683/d519359d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T16:46:03.155825+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"702ccc68c3aeeb1dd2b83121f89b221fe853c847","claim":"INOVIO PHARMACEUTICALS, INC. announced a restructuring with charges of approximately $2.1 million (58 employees).","evidence_excerpt":"On July 31, 2023, Inovio Pharmaceuticals, Inc. (the “ Company ”) committed to and communicated a corporate reorganization plan, including a reduction in force of 58 employees (the “ Reduction ”), representing approximately 30% of its full-time employees. The Company expects to incur a one-time pre-tax charge of approximately $2.1 million in the third quarter of 2023 related to the Reduction, consisting primarily of one-time severance payments upon termination, continued healthcare benefits for a specific period of time, and outplacement services.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1055726/000119312523199683/0001193125-23-199683-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"approximately $2.1 million"},{"label":"Headcount","value":"58 employees"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}